Point72 Middle East FZE’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,800
Closed -$741K 852
2023
Q4
$741K Sell
6,800
-13,300
-66% -$1.38M 0.02% 702
2023
Q3
$2.07M Buy
20,100
+8,400
+72% +$905K 0.07% 342
2023
Q2
$1.35M Sell
11,700
-3,600
-24% -$409K 0.04% 497
2023
Q1
$1.63M Sell
15,300
-15,300
-50% -$1.65M 0.06% 375
2022
Q4
$3.4M Buy
+30,600
New +$3.13M 0.15% 182

Other funds holding MRK

Point72 Middle East FZE's MRK Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Merck (MRK) in Q1 2024, closing a stake of 29,323 shares — an estimated $3.2M sold.

Point72 Middle East FZE first reported a position in MRK in Q4 2022 and held it in 4 quarters. The position peaked at $26M in Q3 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 29,323 Merck shares in Q1 2024, an estimated $3.2M.
  • Point72 Middle East FZE first reported a position in Merck in Q4 2022 and held it in 4 quarters.
  • Point72 Middle East FZE's Merck position peaked at $26M in Q3 2023.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.